CFA
ILI

Carroll Financial Associates’s INTERLEUKIN GENETICS INC ILI Stock Holding History

Carroll Financial Associates’s Portfolio ILI Stock Details ILI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-150
Closed – – 994
2013
Q4 		$0 Hold
150
– – ﹤0.01% 977
2013
Q3 		$0 Hold
150
– – ﹤0.01% 913
2013
Q2 		$0 Buy
+150
New – ﹤0.01% 758

Other funds holding ILI

CL
CPWM LLC Seattle, Washington $1.06B AUM 14.49% 1-Year Est. Return

Carroll Financial Associates's ILI Position: Q1 2014 in Review

Carroll Financial Associates sold out of INTERLEUKIN GENETICS INC (ILI) in Q1 2014, closing a stake of 150 shares.

Carroll Financial Associates first reported a position in ILI in Q2 2013 and held it in 3 quarters. The position peaked at $0 in Q4 2013. 1 fund tracked by Wall St. Rank holds ILI as of Q1 2014.

  • Carroll Financial Associates reported no remaining INTERLEUKIN GENETICS INC position as of Q1 2014 after selling out during the quarter.
  • Carroll Financial Associates sold 150 INTERLEUKIN GENETICS INC shares in Q1 2014.
  • Carroll Financial Associates first reported a position in INTERLEUKIN GENETICS INC in Q2 2013 and held it in 3 quarters.
  • Carroll Financial Associates's INTERLEUKIN GENETICS INC position peaked at $0 in Q4 2013.
  • 1 fund tracked by Wall St. Rank held INTERLEUKIN GENETICS INC as of Q1 2014.

Based on Carroll Financial Associates's 13F filing for Q1 2014, filed 2 May 2014.